Gail Ouellette

Founder, President & Scientific Director

Regroupement québécois des maladies orphelines (RQMO)

Gail Ouellette, PhD, a geneticist and genetic counsellor, is president & Scientific Director of the Regroupement québécois des maladies orphelines (RQMO)/Quebec Coalition of Orphan Diseases. After doing a Ph.D. in molecular genetics and a postdoctoral fellowship in genetic epidemiology, she left the lab and the computer to become a genetic counsellor. During her time in genetics clinics, she started to work with patient organizations in Quebec, co-founded the RQMO in 2010 and set up a bilingual rare disease portal/help line service for rare diseases (iRARE Centre). She is also the creator of an educational website in genetics, simply.

All Sessions by Gail Ouellette

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

12:30 pm

12:30 pm


Paving the Way Forward for Rare Disease Therapies with Lessons Learned from COVID-19

Health Canada is preparing to implement a national strategy to help fund high-cost drugs for rare diseases by 2022–2023. How can you best prepare, and what can we learn from the COVID-19 vaccine journey? Inform your market access strategy with the experience of these market leaders. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines

Chart a course to succeed in the new market access model for rare disease therapies

Agenda: Day 2 Oct 6, 2020